Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 263 results for "hetero drugs"

NPPA reduces prices of 42 drugs by up to 15% and other top pharma news
India Infoline

NPPA reduces prices of 42 drugs by up to 15% and other top pha...

Drug firm Hetero has launched a bloslmllar of Bevaclzumab. used In treating metastatic colorectal cancer (mCRC), under the brand name CIzumabTM'. The product has been approved by Drug Controller General of India (DCGI) and Is recommended as a first-line ... India Infoline, 2 months ago
Hetero launches biosimilar of cancer drug The Hindu, 2 months ago
Hetero’s biosimilar cancer drug Business Line, 2 months ago
[x]  

7 images for hetero drugs

Moneycontrol.com, 4 weeks ago
InnovateLI, 1 month ago
Financial Express, 2 months ago
India Infoline, 1 month ago
Money Today, 2 months ago
The Hindu, 6 months ago
Medagadget.com, 6 months ago

Hetero Healthcare to set up units in three states

Mumbai, Jul 31 () Hetero Healthcare, part of the Rs 7,500-crore Hetero Drugs, is setting up three units in Andhra Pradesh, Telangana and Assam to expand its formulation business in the country. "We are setting up three new units at Andhra Pradesh, ...
 Times of India4 weeks ago PTI - HETEROHEALTH(DCM25) - Hetero Healthcare to set up units in three states  Namibia Press Agency4 weeks ago
[x]  

Avastin Biosimilar Launches in India

Hetero Drugs Ltd. has the launch of a biosimilar for Roche's Avastin® (bevacizumab) in India. Hetero is marketing the drug under the brand name CizumabTM as a treatment for metastatic colorectal cancer. Hetero's launch is the second release of an ...
 JD Supra1 month ago Second Avastin biosimilar launched in India  FiercePharma1 month ago Hetero launches Avastin biosimilar in India  Livemint.com2 months ago

One dead, two hurt in blast at pharma unit

In an explosion at Hetero Drugs unit at Nakkapalli in Visakhapatnam, one worker died on the spot and two were seriously injured, on Wednesday evening.The incident happened when the workers were cuttin...
 The Hindu2 months ago
The Freepress Journal

One worker killed in explosion at Hetero Drugs scrap yard

What is Isobutyl formate? It is a colourless liquid used as a flavour and fragrance ingredient because of its sweet and slightly fruity odour. VISAKHAPATNAM: In yet another industrial mishap in Visakhapatnam, one contract worker was killed and ...
 New Indian Express2 months ago One worker killed in explosion at pharma unit  The Freepress Journal2 months ago Worker killed in explosion at pharma unit  Chandigarh Tribune2 months ago One killed in explosion at Pharma Unit  United News of India2 months ago
[x]  
India Infoline

Hetero Drugs Launches Biosimilar 'Bevacizumab' For The Treatment Of Metastatic Colorectal Cancer (mCRC) Under The Brand Name 'Cizumabtm'

/PRNewswire/ -- Hetero, one of India's leading generic pharmaceutical companies, today announces the launch of Biosimilar 'Bevacizumab' in India for the treatment of metastatic colorectal cancer (mCRC) under the brand name 'CizumabTM' The product ...
 BioSpace2 months ago Hetero launches biosimilar Bevacizumab for cancer  India Infoline2 months ago Hetero Launches Biosimilar #Bevacizumab# for the Treatment of Metastatic Colorectal Cancer (mCRC) Under the Brand Name #Cizumab(TM)#  Newswit.com1 month ago Hetero lança 'Bevacizumab' biossimilar para o tratamento de Cncer Colorretal Metastático (mCRC) com o nome de 'CizumabTM'  Healthcare Dive2 months ago
[x]  
Med India

Biosimilar Bevacizumab for Metastatic Colorectal Cancer Launched in India

One of the generic Indian pharmaceutical companies, Hetero Drugs has launched a biosimilar for the treatment of metastatic colorectal cancer (mCRC) in India. Advertisement The drug called as "Bevacizumab" has been approved by the Drug Controller General of ...
 Med India2 months ago
India Infoline

Six Indian firms ink pact with UN to supply HIV drugs and other top pharma news

Drug firm Zydus Cadila has inked a generic manufacturing pact with the Medicines Patent Pool for manufacturing global pharma major Bristol-Myers Squibb's daclatasvir tablets used in the treatment of Hepatitis C. Indian pharma firms Aurobindo, ...
 India Infoline1 month ago Lupin, 5 Other Pharma Firms Ink Licensing Pact With Medicines Patent Pool  NDTV1 month ago 6 Indian pharma cos ink licensing pact with UN-backed MPP  Business Standard1 month ago Indian pharma cos ink licensing pact with UN-backed MPP  The Freepress Journal1 month ago

BRIEF-Vivus Inc says has files lawsuit -- 8-K

July 27 Vivus Inc * Says lawsuit was filed in response to an abbreviated new drug application filed by Hetero * Vivus Inc says has filed lawsuit in U.S. District court for district of New Jersey against Hetero USA, Inc. and Hetero Labs ...
 Reuters UK1 month ago VIVUS Files Lawsuit Against Hetero for Infringement of Stendra Patents  Stockwatch1 month ago VIVUS : Files Lawsuit Against Hetero for Infringement of Stendra Patents  4 Traders1 month ago VIVUS INC - 10-Q - MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS  Pharmacy Choice3 weeks ago
[x]  
Firstpost.com

Six Indian pharma companies get new licences to supply generic drugs

new generic manufacturing licensing, for antiretrovirals (ARVs) and direct acting anti-viral (DAA) for treating hepatitis C, with seven pharmaceutical companies, six of which are Indian. MPP signed licences with the Hyderabad-based Aurobindo ...
 Firstpost.com1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - hetero drugs
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less